Research Topics
| Uriel HalbreichSummaryAffiliation: University at Buffalo Country: USA Publications
| Collaborators
|
Detail Information
Publications
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich
Department of Psychiatry, University of Buffalo SUNY AB, Buffalo, NY 14214, USA
Contraception 85:19-27. 2012..The study was conducted to investigate continuous daily levonorgestrel 90 mcg/ethinyl estradiol 20 mcg (LNG/EE) on premenstrual dysphoric disorder (PMDD)...
Premenstrual symptoms in young adults born preterm at very low birth weight--from the Helsinki Study of Very Low Birth Weight AdultsSanna Mustaniemi
Diabetes Prevention Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
BMC Womens Health 11:25. 2011..Preterm birth at very low birth weight (VLBW, < 1500g) has a multitude of consequences that extend to adult life, including altered stress responsiveness which could affect the prevalence of premenstrual symptoms...
The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integrationUriel Halbreich
Biobehavior Program, State University of New York at Buffalo, NY 14214, USA
Am J Obstet Gynecol 193:1312-22. 2005..An interdisciplinary approach is needed for better understanding of developmental processes and the development of measurements and interventions to prevent long-term impact on the offspring...- Major depression is not a diagnosis, it is a departure point to differential diagnosis -- clinical and hormonal considerations (a commentary and elaboration on Antonejevic's paper)Uriel Halbreich
State University of New York at Buffalo, 3435 Main Street, Buffalo, NY 14214, USA
Psychoneuroendocrinology 31:16-22; author reply 23-4. 2006..Elucidation of the multiple underlying mechanisms of depressions and anxieties should lead to targeted treatment modalities and improvement of treatment responses... - Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptomsUriel Halbreich
Biobehavioral Program, State University of New York at Buffalo, Hayes Annex C, Ste 1, 3435 Main Street, 14214, USA
J Affect Disord 91:97-111. 2006..Most cited studies were conducted in Western economically developed countries... - Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?Uriel Halbreich
Biobehavior Program, Department of Psychiatry, State University of New York at Buffalo, New York 14214, USA
CNS Drugs 20:523-47. 2006..Such information would also improve understanding of the putative pathophysiological mechanisms underlying PMS and PMDD, and may point to a more specific diagnosis of these conditions... - Culturally-sensitive complaints of depressions and anxieties in womenUriel Halbreich
Biobehavior Research, SUNY University at Buffalo, NY 14214, USA
J Affect Disord 102:159-76. 2007..quot;Cross-cultural sensitivity" emphasizes culturally-appropriate translations of symptoms and questions, assuming that concepts and constructs are applicable... - Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?Uriel Halbreich
Biobehavior Research, State University of New York at Buffalo, Hayes Annex C Ste 1, 3435 Main Street, Buffalo, NY 14214, USA
J Affect Disord 102:245-58. 2007..Women also have a documented higher frequency of comorbid depression and anxiety disorders, and a three-fold higher prevalence of atypical depression... - Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studiesUriel Halbreich
Departments of Psychiatry and Obstetrics and Gynecology, State University of New York at Buffalo, Buffalo, NY 14214, USA
Gynecol Endocrinol 23:123-30. 2007..It is also hoped that the proposed guidelines for quantification of criteria will be used by clinicians and investigators to facilitate diagnostic uniformity in the field as well as adequate treatment modalities when warranted... - Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluationUriel Halbreich
Biobehavior Program, State University of New York at Buffalo, New York 14214, USA
CNS Drugs 21:641-57. 2007.... - Women's reproductive related disorders (RRDs)Uriel Halbreich
Biobehavior Program, SUNY AB, School of Medicine and Biomedical Sciences, Buffalo, NY 14214 3016, United States
J Affect Disord 122:10-3. 2010..These reproductive-life periods include pregnancy, post-partum, the premenstrual and perimenopausal periods... - Algorithm for treatment of premenstrual syndromes (PMS): experts' recommendations and limitationsUriel Halbreich
Biobehavior Program SUNY AB, Buffalo 14214, USA
Gynecol Endocrinol 20:48-56. 2005..The strengths as well as shortcomings of the experts' opinions processes are discussed. Substantial clinically-relevant research and assessments are still needed... - Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practicesMohamed F Mitwally
Department of Gynecology and Obstetrics, State University of New Yorkat Buffalo, Buffalo, NY 14215, USA
Expert Opin Pharmacother 3:1577-90. 2002..The SSRIs are also efficacious when administered intermittently--only during the luteal phase of the menstrual cycle... - Screening for mental illness in primary care clinicsLinda S Kahn
Department of Psychiatry, State University of New York at Buffalo School of Medicine, USA
Int J Psychiatry Med 34:345-62. 2004..A weakness of this study is that the POPR might generate false positive results. Even if this were the case, the rate of previous diagnoses was still extremely low... - Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospitalUriel Halbreich
Biobehavior Research, The State University of New York at Buffalo, Buffalo, NY, USA
CNS Spectr 13:757-61. 2008.... - Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and researchUriel Halbreich
Biobehavioral Research Program, State University of New York at Buffalo, Hayes Annex C, Suite 1, 3435 Main Street, Buffalo, NY 14214, USA
CNS Spectr 9:177-84. 2004..Clarification of the nature and phenotyping of mental and general symptoms during pregnancy is an important step for the development of effective interventions... - Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorderUriel Halbreich
State University of New York at Buffalo School of Medicine, 14215, USA
Obstet Gynecol 100:1219-29. 2002..The goal of the current study was to evaluate the efficacy and tolerability of sertraline for premenstrual dysphoric disorder when treatment was limited to the luteal phase... - The etiology, biology, and evolving pathology of premenstrual syndromesUriel Halbreich
Biobehavioral Program, School of Medicine and Biomedical Sciences, Buffalo, NY 14214 3016, USA
Psychoneuroendocrinology 28:55-99. 2003.... - The pathophysiologic background for current treatments of premenstrual syndromesUriel Halbreich
Biobehavioral Program, State University of New York SUNY at Buffalo, Clinical Center, 462 Grider Street, Buffalo, NY 14215, USA
Curr Psychiatry Rep 4:429-34. 2002..Environmental inputs to pathophysiology, which are not discussed here, have been addressed by attempts at changes of lifestyle, coping style, and environment... - The association of perimenopausal mood disorders with other reproductive-related disordersJudith Feld
Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
CNS Spectr 10:461-70. 2005.... - Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enoughUriel Halbreich
Biobehavior Research, State University of New York at Buffalo, USA
CNS Spectr 13:566-72. 2008..There is a need to examine if this is actually the case. More recently, combined oral contraceptives (COCs) have been pursued due to their ovulation suppression effects. Their effects on PMS/PMDD should be further examined as well... - Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertralineUriel Halbreich
Biobehavioural Program, School of Medicine and Biomedical Sciences, Hayes C, Suite 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
Expert Opin Pharmacother 4:2065-78. 2003.... - The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)Uriel Halbreich
Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
Psychoneuroendocrinology 28:1-23. 2003..Appropriate recognition of the disorder and its impact should lead to treatment of more women with PMS/PMDD. Efficacious treatments are available. They should reduce individual suffering and impact on family, society, and economy... - Anxiety disorders in women: a developmental and lifecycle perspectiveUriel Halbreich
Department of Bio-Behavioral Research, State University of New York, Buffalo, NY, USA
Depress Anxiety 17:107-10. 2003 - Non-Western therapies for affective disorders: in pursuit of open-minded considerations of concepts and applicationsUriel Halbreich
Biobehavior Research, State University of New York at Buffalo, Buffalo, NY, USA
CNS Spectr 14:243-6. 2009..This installment of "The Well-Rounded Brain" will illuminate some non-Western concepts with an example of treatment modality for affective disorders, and compare them to conventional Western approach... - Screening of patients for clinical trials of premenstrual syndrome/premenstrual dysphoric disorder: methodological issuesJudith T Halbreich
Clinical Trials Biobehavioral Program, State University of New York at Buffalo, Hayes Annex C, 3435 Main Street, Buffalo, NY 14214, USA
Psychiatry Res 141:349-52. 2006..It is also questionable whether the eventually selected women actually represent the general population of women with these disorders... - Mental symptoms and disorders during pregnancyUriel Halbreich
Biobehavioral Research Program, State University of New York at Buffalo, Buffalo, New York, USA
CNS Spectr 9:176. 2004 - Bone mineral density and prolactin associations in patients with chronic schizophreniaGeorge Abraham
Department of Psychiatry, Medical College of Pennsylvania, Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA
Schizophr Res 59:17-8. 2003 - The fountain of mental youth. Search for homeostatic and adaptational hormonal processesUriel Halbreich
School of Medicine and Biomedical Sciences, Biobehavioral Program, SUNY at Buffalo, 14214 3016, USA
Psychoneuroendocrinology 29:697-704. 2004..Their elucidation would substantially contribute to understanding of well-being, disorders, and successful as well as unsuccessful aging... - Systematic reviews of clinical trials of acupuncture as treatment for depression: how systematic and accurate are they?Uriel Halbreich
Biobehavior Research, State University of New York at Buffalo, Buffalo, NY, USA
CNS Spectr 13:293-4, 299-300. 2008 - Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label studyZerrin Emel Kayatekin
Department of Psychiatry and Behavioral Sciences, Berkshire Medical Center, Pittsfield, MA 01201, USA
Arch Womens Ment Health 11:207-11. 2008..Anticonvulsant medications, specifically levetiracetam, could be effective in the treatment of PMDD. Future double-blind, placebo controlled, randomized studies are warranted and should include larger number of patients... - Neurobehavioral impact of menopause on moodJeanne Leventhal Alexander
Kaiser Permanente Northern California, Psychiatry Women s Health Program, Oakland, CA, USA
Expert Rev Neurother 7:S81-91. 2007..In most cases, the period of vulnerability to mood problems subsides when the woman's hormonal levels stabilize and she enters full menopause... - The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg
University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
J Clin Psychiatry 65:1114-9. 2004..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo... - The phenomenology of depressions and anxieties in women across different cultures. Guest editor's introduction to the special sectionUriel Halbreich
J Affect Disord 102:155-8. 2007 - Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins in platelet membrane in patients with major depressive disorderYuqing Song
Institute of Mental Health, Peking University, China
J Affect Disord 98:253-7. 2007..Thus, the objective of this study is to investigate the therapeutic effect of EA on GTP-binding-protein (G protein) in platelet membrane using fluoxetine as a comparison... - Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diariesLee S Cohen
Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Obstet Gynecol 100:435-44. 2002..To evaluate premenstrual daily dosing with fluoxetine for treatment of premenstrual dysphoric disorder... - Role of stressful life events and menopausal stage in wellbeing and healthJeanne Leventhal Alexander
Psychiatry Women s Health Program, Kaiser Permanente Northern California, Oakland, CA, USA
Expert Rev Neurother 7:S93-113. 2007..Strategies for the optimal approach for clinicians to evaluate and treat the symptomatic perimenopausal patient with stressful life events and comorbid mood disorders are presented... - Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosisJeanne Leventhal Alexander
Kaiser Permanente Northern California, Psychiatry Women s Health Program, Oakland, CA, USA
Expert Rev Neurother 7:S15-26. 2007..Familiarity with the differential diagnosis, pathophysiology and evidence-based treatment for such patients is crucial to their proper care... - Postpartum disorders: multiple interacting underlying mechanisms and risk factorsUriel Halbreich
J Affect Disord 88:1-7. 2005 - Perimenopausal mental disorders: epidemiology and phenomenologyNatalie Rasgon
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Standord, CA 94305 5723, USA
CNS Spectr 10:471-8. 2005..At this time, more research is needed to address questions of prevalence, risk, and etiology for depression and other major mental disorders as related to the physiological and psychosocial changes associated with perimenopause...